Φορτώνει......
Treatment Selection for Patients With Metastatic Renal Cell Carcinoma
The availability of approved agents with distinct mechanisms of action has encouraged investigations to identify optimal treatment strategies for specific patients and specific tumor features. Study of tumors from patients treated with interleukin 2 (IL-2) has suggested that response was unlikely in...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2009
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2762357/ https://ncbi.nlm.nih.gov/pubmed/19402069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24231 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|